Your browser doesn't support javascript.
loading
Positive Expiratory Pressure for the Treatment of Acute Asthma Exacerbations: A Randomized Controlled Trial.
Navanandan, Nidhya; Federico, Monica; Mistry, Rakesh D.
Afiliação
  • Navanandan N; Children's Hospital Colorado, University of Colorado School of Medicine, Section of Pediatric Emergency Medicine, Aurora, CO. Electronic address: Nidhya.Navanandan@childrenscolorado.org.
  • Federico M; Children's Hospital Colorado, University of Colorado School of Medicine, Section of Pediatric Pulmonary Medicine, Aurora, CO.
  • Mistry RD; Children's Hospital Colorado, University of Colorado School of Medicine, Section of Pediatric Emergency Medicine, Aurora, CO.
J Pediatr ; 185: 149-154.e2, 2017 06.
Article em En | MEDLINE | ID: mdl-28284473
OBJECTIVES: To evaluate the efficacy of brief, single administration of positive expiratory pressure (PEP) therapy in reducing clinical severity and need for additional second-line therapies and hospitalization in children presenting to the emergency department (ED) with acute asthma. STUDY DESIGN: This was a prospective randomized controlled trial of children 2-18 years of age presenting to a tertiary-care academic pediatric ED with moderate-to-severe asthma exacerbations from December 2014 to June 2016. Children who continued to have moderate asthma severity after completion of initial therapies (albuterol/ipratropium bromide and corticosteroids) were randomized to receive PEP therapy or standard of care. The primary outcome was change in pulmonary asthma score before and after intervention, as assessed by a blinded physician. Secondary outcomes included need for additional therapies, ED length of stay, and disposition. RESULTS: A total of 52 patients were randomized to receive either PEP (n?=?26) or standard therapy (n?=?26). Study groups were similar in demographics and baseline characteristics. There was no significant difference in primary outcome between groups with a mean change in Pulmonary Asthma Score of 0.92 (±1.2) in the PEP group and 0.40 (±1.2) in the standard group (P?=?.12). There also was no significant difference in need for additional therapies, ED length of stay, and disposition. Mild, self-resolving side effects were observed in 3 subjects receiving PEP therapy. CONCLUSION: Single, brief, administration of PEP therapy after completion of first-line therapies does not improve clinical severity in children presenting to the ED with acute asthma. TRIAL REGISTRATION: ClinicalTrials.gov: NCT02494076.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Respiração com Pressão Positiva Tipo de estudo: Clinical_trials / Observational_studies Limite: Child / Female / Humans / Male Idioma: En Revista: J Pediatr Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Respiração com Pressão Positiva Tipo de estudo: Clinical_trials / Observational_studies Limite: Child / Female / Humans / Male Idioma: En Revista: J Pediatr Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos